Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 6/20 | 0.62 |
| ▸ | POLB | P06746 | 1/20 | 0.62 |
| ▸ | HTT | P42858 | 4/20 | 0.61 |
| ▸ | GLO1 | Q04760 | 3/20 | 0.61 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.61 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.56 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.56 |
| ▸ | MAPT | P10636 | 5/20 | 0.54 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.54 |
| ▸ | LMNA | P02545 | 2/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.54 |
| ▸ | MMP2 | P08253 | 2/20 | 0.54 |
| ▸ | TSHR | P16473 | 2/20 | 0.54 |
| ▸ | GMNN | O75496 | 1/20 | 0.54 |
| ▸ | TP53 | P04637 | 1/20 | 0.54 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.54 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.54 |
| ▸ | MMP9 | P14780 | 1/20 | 0.54 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.54 |
| ▸ | MMP8 | P22894 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL28172351 | 0.98 | TDP1 (0.60) | TDP1POLBHTTGLO1ALOX15 | |
| Quinoline SCHEMBL28127501 | 0.89 | ALDH1A1 (0.57) | TDP1POLBHTTGLO1ALOX15 | |
| SCHEMBL16029958 | 0.85 | TDP1 (0.52) | TDP1POLBHTTGLO1ALOX15 | |
| SCHEMBL18768618 | 0.84 | TDP1 (0.58) | TDP1POLBHTTGLO1ALOX15 | |
| SCHEMBL379216 | 0.83 | GLO1 (0.59) | TDP1POLBHTTGLO1ALOX15 | |
| SCHEMBL2622219 | 0.82 | HTT (0.56) | TDP1POLBHTTGLO1ALOX15 | |
| SCHEMBL7774451 | 0.79 | CYP3A4 (0.61) | TDP1POLBHTTGLO1ALOX15 | |
| SCHEMBL13337941 | 0.79 | MEN1 (0.56) | TDP1POLBHTTGLO1ALOX15 | |
| SCHEMBL31130165 | 0.79 | CYP3A4 (0.61) | TDP1POLBHTTGLO1ALOX15 | |
| SCHEMBL17749155 | 0.79 | GLO1 (0.56) | TDP1POLBHTTGLO1ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 119 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110669058-A | Tricyclic quinolone carboxylic acid and preparation method thereof | 江西农业大学 | 2020-01-10 | — | — | CN | claimed |
| CN-104620104-B | Affinity Reagents for Protein Purification | 非凡食品有限公司 | 2017-03-01 | — | — | CN | claimed |
| CN-102649786-A | Preparation method for 2, 4-diamino-5-(8-dimethylamino-7-methyl-5-quinolyl Methyl)-2, 4-(1H and 3H) pyrimidine | ZHENGZHOU FUYUAN ANIMAL PHARMACEUTICAL CO LTD | 2012-08-29 | — | — | CN | claimed |
| US-20230329081-A1 | Light Emitting Device and Composition | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2023-10-12 | — | — | US | disclosed |
| US-20230329081-A1 | Light Emitting Device and Composition | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2023-10-12 | — | — | US | disclosed |
| US-20230320113-A1 | Light Emitting Device and Composition | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2023-10-05 | — | — | US | disclosed |
| US-20230320113-A1 | Light Emitting Device and Composition | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2023-10-05 | — | — | US | disclosed |
| US-20230303537-A1 | NITROGEN-CONTAINING COMPOUND, AND ELECTRONIC ELEMENT AND ELECTRONIC DEVICE THEREOF | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2023-09-28 | — | — | US | disclosed |
| EP-3932927-B1 | METAL COMPLEX AND COMPOSITION INCLUDING SAID METAL COMPLEX | SUMITOMO CHEMICAL CO (JP) | 2023-09-27 | — | — | EP | disclosed |
| US-11770941-B2 | Film production method | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2023-09-26 | — | — | US | disclosed |
| US-11770941-B2 | Film production method | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2023-09-26 | — | — | US | disclosed |
| US-7005489-B2 | Zwitterionic Metallocycles | EQUISTAR CHEMICALS, LP (US) | 2006-02-28 | — | — | US | disclosed |
| WO-2005033154-A1 | ZWITTERIONIC METALLOCYCLES | EQUISTAR CHEMICALS, LP (US) | 2005-04-14 | — | — | WO | disclosed |
| US-20050070728-A1 | Zwitterionic metallocycles | EQUISTAR CHEMICALS, LP | 2005-03-31 | — | — | US | disclosed |
| WO-1999029670-A2 | AMINOCARBONYLTETRALIN AND DIHYDRONAPHTALENE DERIVATES AS THROMBIN INHIBITORS | BOEHRINGER INGELHEIM PHARMA KG (DE) | 1999-06-17 | — | — | WO | disclosed |
| US-5405843-A | Anticancer drug potentiators | MITSUI TOATSU CHEMICALS, INCORPORATED (JP) | 1995-04-11 | — | — | US | disclosed |
| EP-0363212-B1 | Novel heterocyclic compounds and anticancer-drug reinforcing agents containing them as effective components | MITSUI TOATSU CHEMICALS (JP) | 1995-01-04 | — | — | EP | disclosed |
| US-5204348-A | Quinoline derivatives | MITSUI TOATSU CHEMICALS INC. (JP) | 1993-04-20 | — | — | US | disclosed |
| US-5112817-A | Anticancer Drug Potentiators | MITSUI TOATSU CHEMICALS, INCORPORATED (JP) | 1992-05-12 | — | — | US | disclosed |
| US-4113717-A | Quaternized azo dyestuffs | IMPERIAL CHEMICAL INDUSTRIES LIMITED (GB) | 1978-09-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050070728-A1 | Zwitterionic metallocycles | ZW10, ZKSCAN2, SLC39A14 | TDP1 4431/4885POLB 152/4885HTT 4611/4885 |
| US-20230303537-A1 | NITROGEN-CONTAINING COMPOUND, AND ELECTRONIC ELEMENT AND ELECTRONIC DEVICE THEREOF | NPM1, NFE2L2, MNS1 | TDP1 2031/4885POLB 2160/4885HTT 3849/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.